Please use this identifier to cite or link to this item:
|Title:||Selection of novel peptides homing alternative targets in triple negative breast cancer|
Silva, Vera Lúcia Domingues
Nóbrega, Franklin Luzia
Martins, Ivone M.
Rodrigues, L. R.
|Citation:||Ferreira, Débora; Silva, V.; Nóbrega, Franklin L.; Martins, Ivone M.; Kluskens, Leon D.; Rodrigues, Lígia R., Selection of novel peptides homing alternative targets in triple negative breast cancer. BOD 2017 - Bioinformatics Open Days (Book Conference). Braga, Feb 23-24, 2017.|
|Abstract(s):||[Excerpt] Breast cancer is the most frequent cancer amongst women, representing 25% of all cancer cases, with an estimated 1.67 million new cases in 2012 1. Phenotypically characterized by the lack of known receptors, the triple negative breast cancer (TNBC) subtype is responsible for 10 to 20% of all diagnosed breast cancers 2. Due to its unique profile, aggressive behavior and different patterns of metastasis, the search for effective diagnosis and treatment tools has intensified 3. However, the lack of specific cell targeting remains the main barrier for sensitive diagnostic tools. [...]|
|Appears in Collections:|